Evolent Health, Inc (EVH) financial statements (2020 and earlier)
Company profile
| Business Address |
800 NORTH GLEBE RD, SUITE 500 ARLINGTON, VA 22203 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 8741 - Management Services (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 206 | 228 | 238 | 179 | 155 | ||
| Cash and cash equivalents | 97 | 228 | 238 | 135 | 146 | ||
| Short-term investments | 4 | 44 | 9 | ||||
| Other undisclosed cash, cash equivalents, and short-term investments | 105 | ||||||
| Restricted cash and investments | 101 | 155 | 62 | 34 | 5 | ||
| Receivables | 72 | 78 | 75 | 51 | 20 | ||
| Contract with customer, asset | 1 | 2 | ✕ | ✕ | ✕ | ||
| Other undisclosed current assets | (73) | 24 | 3 | 1 | 4 | ||
| Total current assets: | 308 | 488 | 378 | 265 | 184 | ||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 76 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 83 | 74 | 51 | 31 | 13 | ||
| Long-term investments and receivables | 71 | 13 | 2 | 2 | 45 | ||
| Long-term investments | 71 | 6 | 2 | 2 | 45 | ||
| Accounts and financing receivable, after allowance for credit loss | 0 | 7 | |||||
| Intangible assets, net (including goodwill) | 1,089 | 1,103 | 869 | 885 | 772 | ||
| Goodwill | 772 | 768 | 628 | 627 | 609 | ||
| Intangible assets, net (excluding goodwill) | 317 | 335 | 241 | 259 | 163 | ||
| Contract with customer, asset, net | 1 | 1 | ✕ | ✕ | ✕ | ||
| Capitalized contract cost, net | 30 | 19 | ✕ | ✕ | ✕ | ||
| Restricted cash and investments | 8 | 6 | 3 | 6 | 2 | ||
| Other noncurrent assets | 8 | ||||||
| Other undisclosed noncurrent assets | 40 | 18 | 9 | 10 | |||
| Total noncurrent assets: | 1,406 | 1,234 | 935 | 935 | 831 | ||
| TOTAL ASSETS: | 1,714 | 1,722 | 1,313 | 1,200 | 1,016 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 189 | 221 | 108 | 111 | 45 | ||
| Accounts payable | 120 | 147 | 43 | 44 | 17 | ||
| Accrued liabilities | 42 | 49 | 30 | 29 | 6 | ||
| Employee-related liabilities | 27 | 25 | 35 | 38 | 22 | ||
| Deferred revenue | 23 | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 5 | ||||||
| Due to related parties | 1 | 1 | |||||
| Deferred revenue and credits | ✕ | ✕ | 25 | 20 | 15 | ||
| Contract with customer, liability | ✕ | 21 | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 42 | 27 | |||||
| Total current liabilities: | 260 | 269 | 133 | 132 | 60 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 71 | ||||||
| Operating lease, liability | 71 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 31 | 19 | 12 | 36 | 21 | ||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Contract with customer, liability | ✕ | 2 | ✕ | ✕ | ✕ | ||
| Deferred tax liabilities, net | ✕ | 2 | 21 | 21 | |||
| Deferred income tax liabilities | 25 | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 7 | 17 | 10 | 15 | 0 | ||
| Other undisclosed noncurrent liabilities | 228 | 245 | 121 | 120 | |||
| Total noncurrent liabilities: | 330 | 264 | 134 | 156 | 21 | ||
| Total liabilities: | 590 | 533 | 266 | 288 | 81 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | 1,108 | 1,144 | 1,011 | 703 | 649 | ||
| Additional paid in capital | 1,162 | 1,093 | 924 | 555 | 342 | ||
| Accumulated other comprehensive loss | (0) | (0) | |||||
| Retained earnings (accumulated deficit) | (54) | 50 | 86 | 147 | 307 | ||
| Other undisclosed stockholders' equity attributable to parent | 1 | 1 | 1 | 1 | 1 | ||
| Stockholders' equity attributable to noncontrolling interest | 16 | 46 | 35 | 210 | 285 | ||
| Total stockholders' equity: | 1,124 | 1,189 | 1,046 | 912 | 935 | ||
| TOTAL LIABILITIES AND EQUITY: | 1,714 | 1,722 | 1,313 | 1,200 | 1,016 | ||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Revenues | 803 | 627 | 435 | 254 | 97 | |
| Revenue, net | ✕ | ✕ | 435 | 254 | 97 | |
| Cost of revenue (Policyholder Benefits and Claims Incurred, Net) | (1) | |||||
| Other undisclosed gross profit | (1) | |||||
| Gross profit: | 802 | 626 | 435 | 254 | 97 | |
| Operating expenses | (908) | (675) | (508) | (492) | (140) | |
| Other undisclosed operating income | 1 | 1 | ||||
| Operating loss: | (105) | (47) | (73) | (237) | (43) | |
| Nonoperating income | 3 | 4 | 2 | 414 | ||
| Investment income, nonoperating | 4 | 3 | 2 | 414 | ||
| Interest and debt expense | (14) | (5) | (4) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | (116) | (49) | (75) | (237) | 371 | |
| Loss from equity method investments | (8) | (5) | (2) | (1) | (28) | |
| Other undisclosed income from continuing operations before income taxes | 0 | 1 | 0 | |||
| Income (loss) from continuing operations before income taxes: | (124) | (54) | (76) | (238) | 343 | |
| Income tax expense (benefit) | (0) | (0) | 7 | 11 | (23) | |
| Net income (loss): | (124) | (54) | (70) | (227) | 320 | |
| Net income attributable to noncontrolling interest | 3 | 2 | 9 | 67 | 13 | |
| Net income (loss) attributable to parent: | (121) | (53) | (61) | (160) | 332 | |
| Preferred stock dividends and other adjustments | (2) | |||||
| Net income (loss) available to common stockholders, basic: | (121) | (53) | (61) | (160) | 330 | |
| Convertible preferred dividends | 2 | |||||
| Other undisclosed net loss available to common stockholders, diluted | (13) | |||||
| Net income (loss) available to common stockholders, diluted: | (121) | (53) | (61) | (160) | 320 | |
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (124) | (54) | (70) | (227) | 320 | |
| Other undisclosed comprehensive income (loss) | 0 | (0) | ||||
| Comprehensive income (loss): | (124) | (54) | (70) | (227) | 320 | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 3 | 2 | 9 | 67 | 13 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (121) | (53) | (61) | (160) | 332 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.